GUERINI ROCCO, ELENA
GUERINI ROCCO, ELENA
Dipartimento di Oncologia ed Emato-Oncologia
Molecular tumor board in patients with metastatic breast cancer
2025 L. Boscolo Bielo, E. Guerini Rocco, E. Crimini, M. Repetto, M. Lombardi, C. Zanzottera, G. Aurilio, M. Barberis, C. Belli, Y. Zhan, E. Battaiotto, J. Katrini, R. Marsicano, P. Zagami, B. Taurelli Salimbeni, A. Esposito, D. Trapani, C. Criscitiello, N. Fusco, A. Marra, G. Curigliano
Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact
2025 K. Venetis, C. Frascarelli, L.B. Bielo, G. Cursano, R. Adorisio, M. Ivanova, E. Mane, V. Peruzzo, A. Concardi, M. Negrelli, M. D'Ercole, F.M. Porta, Y. Zhan, A. Marra, D. Trapani, C. Criscitiello, G. Curigliano, E. Guerini-Rocco, N. Fusco
ESR1 testing on FFPE samples from metastatic lesions in HR + /HER2- breast cancer after progression on CDK4/6 inhibitor therapy
2025 K. Venetis, G. Cursano, R. Scafetta, P.P.M.B. Giachetti, A. Concardi, E. De Camilli, M. D'Ercole, E. Mane, C. Frascarelli, A. Marra, S. Gandini, F. Pepe, S. Scagnoli, S.M. Rossi, R. Troiano, E. Speziale, C. De Angelis, G. Troncone, U. Malapelle, G. Perrone, A. Botticelli, G. Viale, G. Curigliano, E. Guerini Rocco, C. Criscitiello, N. Fusco
Inter-Assay Variability of TROP2 Immunohistochemistry in Triple-Negative Breast Cancer
2025 G. Cursano, A. Concardi, M. Ivanova, C. Frascarelli, E. Mane, E. Mangione, S. Santaguida, D. Tosoni, S. Pece, A. Marra, C. Criscitiello, G. Curigliano, G. Viale, K. Venetis, E.G. Rocco, N. Fusco
Cervical stromal invasion and molecular characterization in stage II-IV endometrial cancers
2025 L.A. De Vitis, F.E. Reyes-Baez, G. Schivardi, M. Shahi, A.J. Fought, M.E. Mcgree, I. Capasso, L. Grcevich, I. Betella, M. Ghioni, E. Guerini-Rocco, G.D. Aletti, W. Cliby, F. Multinu, C.L. Langstraat, A. Mariani, G.E. Glaser
The Regulatory Landscape of Biobanks In Europe: From Accreditation to Intellectual Property
2025 A. Corradi, G. Bonizzi, E. Sajjadi, F. Pavan, M. Fumagalli, L.O. Molendini, M. Monturano, C. Cassi, C.R. Musico, L. Leoni, C. Frascarelli, O. Pala, E.G. Rocco, A. Albini, R. Orecchia, N. Fusco
Multimodal histopathologic models stratify hormone receptor-positive early breast cancer
2025 K.M. Boehm, O.S.M. El Nahhas, A. Marra, M. Waters, J. Jee, L. Braunstein, N. Schultz, P. Selenica, H.Y. Wen, B. Weigelt, E.D. Paul, P. Cekan, R. Erber, C.M.L. Loeffler, E. Guerini-Rocco, N. Fusco, C. Frascarelli, E. Mane, E. Munzone, S. Dellapasqua, P. Zagami, G. Curigliano, P. Razavi, J.S. Reis-Filho, F. Pareja, S. Chandarlapaty, S.P. Shah, J.N. Kather
Investigating the Pathogenicity of Uncommon KRAS Mutations and Their Association with Clinicopathologic Characteristics in Patients with Colorectal Cancer
2025 R. Adorisio, D. Ciardiello, A. Rappa, L. Gervaso, G. Pelizzari, L. Marinucci, N. Fusco, M.G. Zampino, N. Fazio, K. Venetis, E. Guerini-Rocco
The pathologic and genomic evolution of primary malignant phyllodes tumors of the breast: retrospective cohort study and case-control genomic analysis
2025 C. Valenza, D. Trapani, F.M. Porta, E. Olmeda, A. Gaeta, L. Boscolo Bielo, F. Conversano, T.M. De Pas, G. Castellano, C. Santoro, E. Battaiotto, E. Mane, S. Coppola, F. Conforti, D. Mattar, S. Gandini, P. Veronesi, E. Guerini Rocco, E. Pennacchioli, G. Curigliano
Digital counting of tissue cells for molecular analysis: the QuANTUM pipeline
2025 V. L'Imperio, G. Cazzaniga, M. Mannino, D. Seminati, F. Mascadri, J. Ceku, G. Casati, F. Bono, C. Eloy, E.G. Rocco, C. Frascarelli, M. Fassan, U. Malapelle, F. Pagni
Detecting BRAF mutations in colorectal cancer in clinical practice: An Italian experts' position paper
2025 U. Malapelle, V. Angerilli, R. Intini, F. Bergamo, C. Cremolini, F. Grillo, E. Guerini Rocco, T.P. Latiano, E. Martinelli, N. Normanno, F. Pagni, P. Parente, A. Pastorino, F. Pietrantonio, L. Salvatore, S. Lonardi, M. Fassan
Implementing digital pathology: qualitative and financial insights from eight leading European laboratories
2025 X. Matias-Guiu, J. Temprana-Salvador, P. Garcia Lopez, S. Kammerer-Jacquet, N. Rioux-Leclercq, D. Clark, C.M. Schürch, F. Fend, S. Mattern, D. Snead, N. Fusco, E. Guerini-Rocco, F. Rojo, M. Brevet, M. Salto Tellez, A. Dei Tos, T. Di Maio, S. Ramírez-Peinado, E. Sheppard, H. Bannister, A. Gkiokas, M. Arpaia, O. Ben Dhia, N. Martino
The prognostic impact of molecular classification in endometrial cancer that undergoes fertility-sparing treatment
2025 L.A. De Vitis, G. Schivardi, S. Delfrati, B. Biffi, A. Viscardi, M. Rosanu, L. Ribero, G. Caruso, A. Rappa, L. Marinucci, R. Adorisio, V. Zanagnolo, G.D. Aletti, M. Barberis, E. Guerini-Rocco, F.A. Peccatori, A.V. Urbinati, I. Pino, D. Franchi, I. Betella, N. Colombo, F. Multinu
Invasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research group
2025 G. Corso, S. Shen, C. Criscitiello, R. Mukhtar, L. Gamble, E.G. Rocco, F. Pesapane, L. Nicosia, K. Jhaveri, B.T. Salimbeni, G. Massari, E. Meduri, A.M. De Scalzi, A. Concardi, F. Magnoni, A. Mamtani, F. Pareja, M.C. Leonardi, V. Sacchini, G. Bogani, C.L. Vecchia, D. Presti, M.A. Colleoni, P. Veronesi, M.E. Robson
Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients
2025 D. Lorenzini, G. Gaudioso, A. Scardoni, L. Blandi, A. Del Gobbo, P. Rafaniello Raviele, S. Ferrero, S.M. Veronese, C. Lauricella, F. Pagni, D. Seminati, M. Miozzo, C. Pesenti, U. Gianelli, S. Buiatiotis, C. Fumagalli, E. Guerini Rocco, A. Rappa, M. Barberis, N. Fusco, A. Ranghiero, S. La Rosa, F. Sessa, D. Furlan, N. Sahnane, C. Patriarca, M.G. Cangi, A. Lume, C. Doglioni, M. Ponzoni, W. Vermi, M. Novali, M. Paulli, E. Boveri, L. Terracciano, S. Uccella, A. Destro, E. Tamborini, F. Perrone, F. Pasotti, F. Agustoni, F. De Braud, F. Grossi, S. Siena, G. Curigliano, S. Buoro, G. Pruneri
Clinicopathological characteristics of multiple-classifier endometrial cancers: a cohort study and systematic review
2024 L. Antonio De Vitis, G. Schivardi, G. Caruso, C. Fumagalli, D. Vacirca, M. Teresa Achilarre, A. Aloisi, A. Garbi, V. Zanagnolo, G. Aletti, E. Guerini-Rocco, A. Mariani, A. Maggioni, M. Barberis, G. Bogani, N. Colombo, F. Multinu, I. Betella
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories
2024 F. Pepe, K. Venetis, G. Cursano, C. Frascarelli, P. Pisapia, D. Vacirca, C. Scimone, A. Rappa, G. Russo, E. Mane, F. Pagni, I. Castellano, G. Troncone, C.D. Angelis, G. Curigliano, E. Guerini-Rocco, U. Malapelle, N. Fusco
Expression of immune-related genes and breast cancer recurrence in women with ductal carcinoma in situ
2024 E. Guerini-Rocco, F. Bellerba, A. Concardi, S.V. Taormina, G. Cammarata, C. Fumagalli, A. Guerrieri-Gonzaga, D. Macis, E. Del Fiol Manna, E. Balladore, M. Cannone, P. Veronesi, N. Fusco, B. Bonanni, G. Viale, M. Barberis, S. Gandini, M. Lazzeroni
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer
2024 M. Ivanova, F.M. Porta, M. D'Ercole, C. Pescia, E. Sajjadi, G. Cursano, E. De Camilli, O. Pala, G. Mazzarol, K. Venetis, E. Guerini-Rocco, G. Curigliano, G. Viale, N. Fusco
CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype
2024 G. Corso, E. Marino, C. Zanzottera, C. Oliveira, L. Bernard, D. Macis, J. Figueiredo, J. Pereira, P. Carneiro, G. Massari, M. Barberis, A.M. De Scalzi, S.V. Taormina, E. Sajjadi, C. Sangalli, S. Gandini, O. D'Ecclesiis, C.M. Trovato, A. Rotili, F. Pesapane, L. Nicosia, C. La Vecchia, V. Galimberti, E. Guerini-Rocco, B. Bonanni, P. Veronesi